» Articles » PMID: 26383625

Depression and Hopelessness in Patients with Acute Leukemia: the Psychological Impact of an Acute and Life-threatening Disorder

Overview
Journal Psychooncology
Publisher Wiley
Specialties Oncology
Psychology
Date 2015 Sep 19
PMID 26383625
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Acute leukemia (AL) is a life-threatening cancer associated with substantial morbidity and mortality, particularly in older adults. Given that there has been little research on the psychological impact of such malignancies with acute onset, we assessed the prevalence and correlates of depression and hopelessness in patients with AL.

Methods: Three hundred forty-one participants were recruited within 1 month of diagnosis or relapse and completed the Beck Depression Inventory-II (BDI-II), Beck Hopelessness Scale (BHS), Memorial Symptom Assessment Scale, and other psychosocial measures. Multivariate regression analyses identified correlates of depression and hopelessness.

Results: 17.8% reported clinically significant depressive symptoms (BDI-II ≥ 15), 40.4% of which were in the moderate-severe range (BDI-II ≥ 20). 8.5% reported significant symptoms of hopelessness (BHS ≥ 8). Depression was associated with greater physical symptom burden (adjusted R(2)  = 48.4%), while hopelessness was associated with older age and lower self-esteem (adjusted R(2)  = 45.4%). Both were associated with poorer spiritual well-being.

Conclusions: Clinically significant depressive symptoms were common early in the course of AL and related to physical symptom burden. Hopelessness was less common and associated with older age and lower self-esteem. The results suggest that whereas depression in AL may be related to disease burden, the preservation of hope may be linked to individual resilience, life stage, and realistic prognosis.Copyright © 2015 John Wiley & Sons, Ltd.

Citing Articles

Factors Associated with Psychological Well-Being Among Children Under 18 Years Old with Cancer: A Scoping Review.

Alya F, Hendrawati S, Mediani H Psychol Res Behav Manag. 2025; 18():39-53.

PMID: 39807478 PMC: 11727497. DOI: 10.2147/PRBM.S488905.


Short-Term Impact of Hematopoietic Stem Cell Transplantation on Depressive Behavior, Cognition and Quality of Life in Leukemia Patients.

Joshi R, Garg A, Khan Z, Bhurani D, Nidhi , Khan M Indian J Hematol Blood Transfus. 2024; 40(1):83-90.

PMID: 38312172 PMC: 10831021. DOI: 10.1007/s12288-023-01653-2.


Examining the levels of psychological support available to patients with haematological cancer in England: a mixed methods study.

Brett J, Henshall C, Dawson P, Collins G, Ehlers A, Mitchell-Floyd T BMJ Open. 2023; 13(2):e060106.

PMID: 36806143 PMC: 9943904. DOI: 10.1136/bmjopen-2021-060106.


Early integration of palliative care for patients with haematological malignancies.

Shaulov A, Aviv A, Alcalde J, Zimmermann C Br J Haematol. 2022; 199(1):14-30.

PMID: 35670630 PMC: 9796711. DOI: 10.1111/bjh.18286.


Psychotropic Drug Use in Acute Myeloid Leukaemia (AML) and Myelodysplastic Syndrome (MDS): A Danish Nationwide Matched Cohort Study of 2404 AML and 1307 MDS Patients.

Jensen O, Ovlisen A, Jakobsen L, Roug A, Nielsen R, Marcher C Clin Epidemiol. 2022; 14:225-237.

PMID: 35241936 PMC: 8887140. DOI: 10.2147/CLEP.S336115.